SYSTEM UPDATE: We will be performing system maintenace Saturday September 26 at 9pm to midnight Pacific Time

Searching the RRID Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
Protocol Name
MojoSort™ Mouse CD4 Nanobeads Protocol
DOI:DOI:10.17504/protocols.io.7wthpen RRID Copied  
PDF Report How to cite
Sam Li 2019. MojoSort™ Mouse CD4 Nanobeads Protocol. protocols.io https://dx.doi.org/10.17504/protocols.io.7wthpen
Copy Citation Copied
Protocol Information

URL: https://dx.doi.org/DOI:10.17504/protocols.io.7wthpen

Authors: Sam Li

Group: BioLegend

Summary: Product description and procedure summary:The cells targeted by the Nanobeads are either selected or depleted by incubating your sample with the directly conjugated magnetic particles. The magnetically labeled fraction is retained by the use of a magnetic separator. After collection of the targeted cells, downstream applications include functional assays, gene expression, phenotypic characterization, etc. Note: This procedure is optimized for the isolation of 107 to 2 x 108 cells per tube. If working with fewer than 107 cells, keep volumes as indicated for 107 cells. For best results, optimize the conditions to your specific cell number and tissue. Prepare fresh MojoSort™ Buffer solution by diluting the 5X concentrate with sterile distilled water. Scale up volumes if using 14mL tubes and Magnet, and place the tube in the magnet for 10 minutes.

Affiliations: BioLegend

External URL: https://www.biolegend.com/protocols/mojosort-mouse-cd4-nanobeads-protocol/4314/

Version: 1

Publication Date: 2019

Expand All
Usage and Citation Metrics

Coming soon.

Checkfor resource mentions.

Collaborator Network

Coming soon.

Data and Source Information

Source: